---
title: 'Cancer cachexia: biomarkers and the influence of age'
date: '2024-02-28'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38414161/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240228170637&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: Cancer cachexia (Ccx) is a complex metabolic condition characterized
  by pronounced muscle and fat wasting, systemic inflammation, weakness and fatigue.
  Up to 30% of cancer patients succumb directly to Ccx, yet therapies that effectively
  address this perturbed metabolic state are rare. In recent decades, several characteristics
  of Ccx have been established in mice and humans, of which we here highlight adipose
  tissue dysfunction, muscle wasting and systemic inflammation, as they are ...
disable_comments: true
---
Cancer cachexia (Ccx) is a complex metabolic condition characterized by pronounced muscle and fat wasting, systemic inflammation, weakness and fatigue. Up to 30% of cancer patients succumb directly to Ccx, yet therapies that effectively address this perturbed metabolic state are rare. In recent decades, several characteristics of Ccx have been established in mice and humans, of which we here highlight adipose tissue dysfunction, muscle wasting and systemic inflammation, as they are ...